Clinical trial
Assess Safety of Intra-arterial Autologous Myogenic Stem Cell Therapy for m.3243A>G Mutation Carriers
NCT05063721 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assess Safety of Intra-arterial Autologous Myogenic Stem Cell Therapy for m.3243A>G Mutation Carriers
- Lead sponsor
- Maastricht University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 1, 2020
- Completion date
- December 1, 2022
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.